|
|
|||||||||||
Senior House Officer in Psychiatry, Murray Royal Hospital, Muirhall Road, Perth PH2 7BH
Consultant Forensic Psychiatrist, Murray Royal Hospital, Perth PH2 7BH
AIMS AND METHOD
This study aimed to investigate the potential benefits of a low glycaemic index diet in patients with schizophrenia taking clozapine. Seven patients consented to participate in a 5-week pilot study. Measurements were taken of body weight, random blood glucose and cholesterol levels.
RESULTS
The mean weight loss per patient was 2.9 kg in 4 weeks. Random blood glucose levels reduced from a mean of 5.3 mmol/l at the beginning of the study to 4.7 mmol/l at the end.
CLINICAL IMPLICATIONS
A low glycaemic index diet may possibly reduce the substantial cardiovascular risk in patients receiving antipsychotic medication.
This article has been cited by other articles:
![]() |
D. Morgan, M. Sargeant, J. Chukwuma, and G. Hughes Audit of metabolic syndrome in adults prescribed clozapine in community and long-stay in-patient populations Psychiatr. Bull., May 1, 2008; 32(5): 174 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Tarrant Blood glucose testing for adults prescribed atypical antipsychotics in primary and secondary care Psychiatr. Bull., August 1, 2006; 30(8): 286 - 288. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| British Journal of Psychiatry | Advances in Psychiatric Treatment | All RCPsych Journals |